Cary, NC, United States of America

Philip E Hammer

This inventor holds 37 USPTO granted patents and 10 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Biological Control Agents. Top assignees: Agbiome, Inc., Athenix Corporation, Novartis Finance Corporation. Active years: 1997-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip E Hammer. Retrieved from https://idiyas.com/inventor/philip-e-hammer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 

% Patents Active = 78.4

 

 

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 412(Granted Patents)


Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biological Control Agents
Herbicide Resistance
EPSP Synthases
Polypeptides
Pyrrolnitrin
Antipathogenic Substances
GDC Genes
GRG Genes
Plant Transformation
Gene Synthesis
Glyphosate Resistance
37 patents (USPTO):Explore Patents

Title: Inventor Philip E Hammer: Pioneering Innovations in Cary, NC

Introduction: Philip E Hammer is a distinguished inventor based in Cary, North Carolina, known for his groundbreaking contributions to various fields.

Latest Patents: Philip E Hammer's recent patents include advancements in renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With over two decades of experience in the innovation industry, Philip E Hammer has a proven track record of developing cutting-edge solutions that have positively impacted society.

Collaborations: Throughout his career, Philip E Hammer has collaborated with leading research institutions, universities, and companies to bring his inventions to life and make a difference in the world.

Conclusion: Philip E Hammer's passion for innovation and his dedication to creating meaningful change through his inventions make him a respected figure in the inventor community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…